Campaign: Areas of Interest for Cancer Nanotechnology

Targeted nanomedicines for pancreatic cancer

Pancreatic cancer represents the 10th most common cause of new cancer and ranks fourth among cancer-related deaths in the United States. The failure in pancreatic cancer treatment is main due to the presence of a dense and poorly vascularized stroma that increase the drug clearance in the tumors rather than the healthy tissues, decreasing drug bioavailability in the target tissue and leading to significant side effects. ...more »

Submitted by

Voting

0 votes
1 up votes
1 down votes
Active